Log In
Print this Print this

Bronchozym, PulmoXen

  Manage Alerts
Collapse Summary General Information
Company Pharmsynthez JSC
DescriptionInhaled polysialylated recombinant human deoxyribonuclease I (DNase I) using PolyXen delivery technology
Molecular Target DNA ; Deoxyribonuclease I (DNASE1)
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase I
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation
Partner Xenetic Biosciences Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today